AstraZeneca: shares rise after UBS upgrade
(CercleFinance.com) - AstraZeneca shares are up 1.
6% in early morning trading on Monday after UBS upgraded the stock to "neutral" from "sell".
In a note to clients, the brokerage firm said that it has upgraded the share, following its recent fall (-12% over two weeks), on the back of mixed Covid-19 vaccine data.
After the slide, the stock is trading on a "palatable" 13% premium to the sector, UBS wrote in the report.
The brokerage has also raised its target price for the share to 7,500 pence from 7,300 pence.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
6% in early morning trading on Monday after UBS upgraded the stock to "neutral" from "sell".
In a note to clients, the brokerage firm said that it has upgraded the share, following its recent fall (-12% over two weeks), on the back of mixed Covid-19 vaccine data.
After the slide, the stock is trading on a "palatable" 13% premium to the sector, UBS wrote in the report.
The brokerage has also raised its target price for the share to 7,500 pence from 7,300 pence.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.